Its confusing. There are a couple of studies knocking around and the usual misinformation prevailing:
https://www.recoverytrial.net/files/recovery_dexamethasone_statement_160620_v2final.pdf
https://jamanetwork.com/journals/jama/fullarticle/2770277
The latter showed no significant mortality rate differences at 28 days, so again the stats are conflicting (good one WHO, join the disinformation party). The former showed the 35% improvement - the study is poorly worded and represented in my opinion, what is it with these guys being unclear with stats - in the 28-day mortality in those who required ventilation (41%) and reduced it by a fifth in those patients who required oxygen only (25%), and no beneift to others.
I despair at the poor presentation of statistics in this whole escapade and it only continues. MSB will have some very clear statistics from its professionally designed thorough study. Meanwhile it appears Dexamethosone does have some benefit in ventilated patients, but the results are again, not entirely clear.
- Forums
- ASX - By Stock
- MSB
- W.H.O. confirms that cheap steroids reduce Covid deaths 36%
W.H.O. confirms that cheap steroids reduce Covid deaths 36%, page-45
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B |
Open | High | Low | Value | Volume |
95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 29390 | 93.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.5¢ | 14089 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 24054 | 0.935 |
8 | 131583 | 0.930 |
4 | 65851 | 0.925 |
7 | 113334 | 0.920 |
9 | 97006 | 0.915 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 1100 | 1 |
0.950 | 19026 | 2 |
0.955 | 27000 | 2 |
0.960 | 32869 | 2 |
0.965 | 35384 | 2 |
Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online